The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation–mediated 14-3-3 binding-Reference-Cited by-同舟云学术

The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation–mediated 14-3-3 binding

Published:2018-10 Issue:42 Volume:293 Page:16142-16159
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Madigan James P.,Hou Feng,Ye Linlei,Hu Jicheng,Dong Aiping,Tempel Wolfram,Yohe Marielle E.,Randazzo Paul A.,Jenkins Lisa M. Miller^ORCID,Gottesman Michael M.^ORCID,Tong Yufeng^ORCID

Funder

HHS | NIH | National Cancer Institute (NCI)

Structural Genomics Consortium

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference89 articles.

1. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism;Hara;J. Biol. Chem,1998

2. Rheb fills a GAP between TSC and TOR;Manning;Trends Biochem. Sci,2003

3. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome;Menon;Cell,2014

4. Tuberous sclerosis;Curatolo;Lancet,2008

5. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling;Manning;Biochem. Soc. Trans,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 14-3-3ε augments OGT stability by binding with S20-phosphorylated OGT;Journal of Biological Chemistry;2024-09

2. Post-translational regulation of the mTORC1 pathway: A switch that regulates metabolism-related gene expression;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2024-03

3. mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex;Cells;2022-09-13

4. Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021);European Journal of Medicinal Chemistry;2022-08

5. The genetics and diagnosis of pediatric neurocutaneous disorders: Neurofibromatosis and tuberous sclerosis complex;Clinics in Dermatology;2022-07